LARGE B-CELL LYMPHOMA
Clinical trials for LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double attack on lymphoma: CAR-T cells followed by antibody drugs
Disease control Recruiting nowThis study tests whether giving an extra antibody drug (mosunetuzumab or glofitamab) after CAR-T cell therapy can improve outcomes for people with relapsed or refractory large B-cell lymphoma. About 42 participants will receive the combination to see if it leads to more complete …
Matched conditions: LARGE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Apr 29, 2026 00:35 UTC
-
New CAR T-Cell therapy offers hope for Tough-to-Treat lymphoma
Disease control Recruiting nowThis trial tests a new treatment called WZTL-002 for people with large B-cell lymphoma that has come back or not responded to standard chemotherapy. The treatment uses a patient's own immune cells, which are modified in a lab to better fight the cancer. The study will check how w…
Matched conditions: LARGE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Malaghan Institute of Medical Research • Aim: Disease control
Last updated Apr 29, 2026 00:35 UTC
-
Can better Doctor-Patient talk improve lymphoma care?
Knowledge-focused Recruiting nowThis study aims to develop and test a communication training program called Hematolo-GIST for doctors who treat large B-cell lymphoma. The goal is to help doctors better discuss the diagnosis and plan future care with their patients. The study will enroll 48 participants, includi…
Matched conditions: LARGE B-CELL LYMPHOMA
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Apr 29, 2026 00:35 UTC
-
Real-World data on glofitamab: a new hope for lymphoma patients?
Knowledge-focused Recruiting nowThis study looks back at medical records of 250 adults with large B-cell lymphoma who received Glofitamab through a special access program in France. Researchers want to see how effective and safe the drug is in real-world settings, especially for patients whose cancer returned a…
Matched conditions: LARGE B-CELL LYMPHOMA
Sponsor: The Lymphoma Academic Research Organisation • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:01 UTC